Quibim, a Spanish startup focused on AI applications in medical imaging, has successfully raised $50 million in Series A funding. This investment comes as AI technologies increasingly penetrate healthcare fields such as oncology and neurology. Quibim's key offerings include QP-Prostate for improved prostate cancer detection and QP-Insights for processing multi-omics data. With plans for U.S. market growth and past FDA clearance for QP-Prostate, the company aims to innovate further by creating digital twins of the human body for enhanced medical understanding.
QUIBIM has raised $50 million to enhance AI diagnostic tools for medical imaging, aiming to improve disease detection across multiple disciplines in healthcare.
The company plans to create digital twins of the human body to provide dynamic models, enhancing our understanding of health conditions starting from organ and lesion levels.
Collection
[
|
...
]